The use of predictive modelling to determine the likelihood of donor return during the COVID-19 pandemic.

IF 1.5 4区 医学 Q3 HEMATOLOGY
Transfusion Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-08 DOI:10.1111/tme.13071
Richard R Gammon, Salwa Hindawi, Arwa Z Al-Riyami, Ai Leen Ang, Renee Bazin, Evan M Bloch, Kelley Counts, Vincenzo de Angelis, Ruchika Goel, Rada M Grubovic Rastvorceva, Ilaria Pati, Cheuk-Kwong Lee, Massimo La Raja, Carlo Mengoli, Adaeze Oreh, Gopal Kumar Patidar, Naomi Rahimi-Levene, Usharee Ravula, Karl Rexer, Cynthia So-Osman, Jecko Thachil, Michel Toungouz Nevessignsky, Marion Vermeulen
{"title":"The use of predictive modelling to determine the likelihood of donor return during the COVID-19 pandemic.","authors":"Richard R Gammon, Salwa Hindawi, Arwa Z Al-Riyami, Ai Leen Ang, Renee Bazin, Evan M Bloch, Kelley Counts, Vincenzo de Angelis, Ruchika Goel, Rada M Grubovic Rastvorceva, Ilaria Pati, Cheuk-Kwong Lee, Massimo La Raja, Carlo Mengoli, Adaeze Oreh, Gopal Kumar Patidar, Naomi Rahimi-Levene, Usharee Ravula, Karl Rexer, Cynthia So-Osman, Jecko Thachil, Michel Toungouz Nevessignsky, Marion Vermeulen","doi":"10.1111/tme.13071","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) uses sophisticated algorithms to \"learn\" from large volumes of data. This could be used to optimise recruitment of blood donors through predictive modelling of future blood supply, based on previous donation and transfusion demand. We sought to assess utilisation of predictive modelling and AI blood establishments (BE) and conducted predictive modelling to illustrate its use. A BE survey of data modelling and AI was disseminated to the International Society of Blood transfusion members. Additional anonymzed data were obtained from Italy, Singapore and the United States (US) to build predictive models for each region, using January 2018 through August 2019 data to determine likelihood of donation within a prescribed number of months. Donations were from March 2020 to June 2021. Ninety ISBT members responded to the survey. Predictive modelling was used by 33 (36.7%) respondents and 12 (13.3%) reported AI use. Forty-four (48.9%) indicated their institutions do not utilise predictive modelling nor AI to predict transfusion demand or optimise donor recruitment. In the predictive modelling case study involving three sites, the most important variable for predicting donor return was number of previous donations for Italy and the US, and donation frequency for Singapore. Donation rates declined in each region during COVID-19. Throughout the observation period the predictive model was able to consistently identify those individuals who were most likely to return to donate blood. The majority of BE do not use predictive modelling and AI. The effectiveness of predictive model in determining likelihood of donor return was validated; implementation of this method could prove useful for BE operations.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"333-343"},"PeriodicalIF":1.5000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/tme.13071","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) uses sophisticated algorithms to "learn" from large volumes of data. This could be used to optimise recruitment of blood donors through predictive modelling of future blood supply, based on previous donation and transfusion demand. We sought to assess utilisation of predictive modelling and AI blood establishments (BE) and conducted predictive modelling to illustrate its use. A BE survey of data modelling and AI was disseminated to the International Society of Blood transfusion members. Additional anonymzed data were obtained from Italy, Singapore and the United States (US) to build predictive models for each region, using January 2018 through August 2019 data to determine likelihood of donation within a prescribed number of months. Donations were from March 2020 to June 2021. Ninety ISBT members responded to the survey. Predictive modelling was used by 33 (36.7%) respondents and 12 (13.3%) reported AI use. Forty-four (48.9%) indicated their institutions do not utilise predictive modelling nor AI to predict transfusion demand or optimise donor recruitment. In the predictive modelling case study involving three sites, the most important variable for predicting donor return was number of previous donations for Italy and the US, and donation frequency for Singapore. Donation rates declined in each region during COVID-19. Throughout the observation period the predictive model was able to consistently identify those individuals who were most likely to return to donate blood. The majority of BE do not use predictive modelling and AI. The effectiveness of predictive model in determining likelihood of donor return was validated; implementation of this method could prove useful for BE operations.

使用预测模型确定 COVID-19 大流行期间捐赠者返回的可能性。
人工智能(AI)使用复杂的算法从大量数据中 "学习"。根据以往的献血和输血需求,通过对未来血液供应的预测建模,可用于优化献血者招募。我们试图评估预测建模和人工智能血液机构(BE)的使用情况,并进行预测建模以说明其使用情况。我们向国际输血学会成员分发了一份关于数据建模和人工智能的血液机构调查报告。从意大利、新加坡和美国获得了更多匿名数据,利用 2018 年 1 月至 2019 年 8 月的数据为每个地区建立预测模型,以确定在规定月数内捐献的可能性。捐赠时间为 2020 年 3 月至 2021 年 6 月。90 名 ISBT 成员对调查做出了回应。33(36.7%)名受访者使用了预测建模,12(13.3%)名受访者报告使用了人工智能。44(48.9%)名受访者表示他们的机构没有使用预测建模或人工智能来预测输血需求或优化捐献者招募。在涉及三个地点的预测建模案例研究中,预测捐献者回流的最重要变量是意大利和美国以前的捐献次数,以及新加坡的捐献频率。在 COVID-19 期间,每个地区的捐赠率都有所下降。在整个观察期间,预测模型始终能够识别出最有可能返回献血的人。大多数 BE 没有使用预测模型和人工智能。预测模型在确定献血者返回的可能性方面的有效性得到了验证;这种方法的实施可能会对 BE 的运营有所帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transfusion Medicine
Transfusion Medicine 医学-血液学
CiteScore
2.70
自引率
0.00%
发文量
96
审稿时长
6-12 weeks
期刊介绍: Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology. In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews. Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信